The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. (Q33938797)

30 July 2017

title

The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. (English)

1 reference

30 July 2017

0 references

Ronald J Ellis

10

0 references

Igor Grant

series ordinal

11

object named as

Igor Grant

1 reference

30 July 2017

7

Susan Morgello

1 reference

30 July 2017

14

CHARTER Group

1 reference

30 July 2017

12

Scott L Letendre

1 reference

30 July 2017

4

Shruti H Mehta

1 reference

30 July 2017

5

Christina M Marra

1 reference

30 July 2017

9

Benjamin B Gelman

1 reference

30 July 2017

13

Justin C McArthur

1 reference

30 July 2017

2

Rosa M Crum

1 reference

30 July 2017

3

Glenn J Treisman

1 reference

30 July 2017

Edward R Hammond

1

1 reference

30 July 2017

David B Clifford

series ordinal

6

1 reference

30 July 2017

David M Simpson

series ordinal

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

24 June 2014

1 reference

American Journal of Epidemiology

30 July 2017

published in

1 reference

30 July 2017

volume

180

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

297-307

1 reference

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

A screening algorithm for HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Cognitive neuropsychology of HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Review: a gentle introduction to imputation of missing values

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV dementia: an evolving disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

The impact of HIV-associated neuropsychological impairment on everyday functioning

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Presentation of multivariate data for clinical use: The Framingham Study risk score functions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

The meaning and use of the area under a receiver operating characteristic (ROC) curve

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Predictive value of statistical models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

HIV-1 infection and cognitive impairment in the cART era: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Prognosis and prognostic research: Developing a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Selection of important variables and determination of functional form for continuous predictors in multivariable model building

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Neurologic complications of HIV disease and their treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Racial/ethnic disparities in diagnoses of HIV/AIDS--33 states, 2001-2004.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-associated cognitive impairment before and after the advent of combination therapy

29 October 2018

1 reference

12 December 2020

Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women

1 reference

12 December 2020

Prognosis and prognostic research: what, why, and how?

1 reference

12 December 2020

Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartment

1 reference

12 December 2020

Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA

1 reference

12 December 2020

Identifiers

DOI

10.1093/AJE/KWU098

1 reference

30 July 2017

1 reference

30 July 2017

1 reference